Proposing an Affordable Plasma Device for Polymer Surface Modification and Microbial Inactivation DOI Creative Commons
William Chiappim, Felipe Vicente de Paula Kodaira, Gisele de Fátima Soares de Castro

и другие.

Molecules, Год журнала: 2024, Номер 29(17), С. 4270 - 4270

Опубликована: Сен. 9, 2024

This study proposes an affordable plasma device that utilizes a parallel-plate dielectric barrier discharge geometry with metallic mesh electrode, featuring straightforward 3D-printed design. Powered by high-voltage supply adapted from cosmetic device, it operates on atmospheric air, eliminating the need for gas flux. Surface modification of polyethylene treated this was characterized and showed elemental composition after 15 min treatment decreased amount C to ~80 at% due insertion O (~15 at%). Tested against

Язык: Английский

Cold Atmospheric Plasma as a Therapeutic Tool in Medicine and Dentistry DOI
Cristiane Yumi Koga‐Ito, Konstantin Georgiev Kostov, F. Miranda

и другие.

Plasma Chemistry and Plasma Processing, Год журнала: 2023, Номер 44(3), С. 1393 - 1429

Опубликована: Авг. 27, 2023

Язык: Английский

Процитировано

26

Exploring innovative strategies for identifying anti-breast cancer compounds by integrating 2D/3D-QSAR, molecular docking analyses, ADMET predictions, molecular dynamics simulations, and MM-PBSA approaches DOI
Said El Rhabori, Marwa Alaqarbeh,

Yassine El Allouche

и другие.

Journal of Molecular Structure, Год журнала: 2024, Номер 1320, С. 139500 - 139500

Опубликована: Июль 31, 2024

Язык: Английский

Процитировано

8

Recent Findings on Therapeutic Cancer Vaccines: An Updated Review DOI Creative Commons
Sara Sheikhlary, David Humberto Lopez,

Sophia Moghimi

и другие.

Biomolecules, Год журнала: 2024, Номер 14(4), С. 503 - 503

Опубликована: Апрель 21, 2024

Cancer remains one of the global leading causes death and various vaccines have been developed over years against it, including cell-based, nucleic acid-based, viral-based cancer vaccines. Although many effective in vivo clinical studies some FDA-approved, there are major limitations to overcome: (1) developing universal vaccine for a specific is difficult, as tumors with different antigens individuals, (2) tumor may be similar body’s own antigens, (3) possibility recurrence. Therefore, personalized ability distinguish between indispensable. This paper provides comprehensive review types highlights important factors necessary efficient Moreover, application other technologies therapy discussed. Finally, several insights conclusions presented, such using cold plasma stem cells future vaccines, tackle developmental process.

Язык: Английский

Процитировано

7

Generation and measurement of low-temperature plasma for cancer therapy: a historical review DOI Creative Commons
Kenji Ishikawa, Keigo Takeda, S. Yoshimura

и другие.

Free Radical Research, Год журнала: 2023, Номер 57(3), С. 239 - 270

Опубликована: Март 4, 2023

This review provides a description of the historical background development biological applications low-temperature plasmas. The generation plasma, methods and devices, plasma sources, measurements properties, such as electron dynamics chemical species in both gaseous aqueous phases, were assessed. Currently, direct irradiation for discharges contacting surfaces, skin teeth, are related to interactions. Indirect using plasma-treated liquids based on plasma-liquid use these two is rapidly increasing preclinical studies cancer therapy. authors address prospects further developments therapeutic by understanding interactions between living organisms.

Язык: Английский

Процитировано

14

Cold atmospheric plasma (CAP): a revolutionary approach in dermatology and skincare DOI Creative Commons
Ahmad Taha Khalaf, Ahmed N. Abdalla,

Kaixuan Ren

и другие.

European journal of medical research, Год журнала: 2024, Номер 29(1)

Опубликована: Окт. 5, 2024

Язык: Английский

Процитировано

5

Advancing chronic and acute wound healing with cold atmospheric plasma: cellular and molecular mechanisms, benefits, risks, and future directions DOI Creative Commons

Nastaran Raissi-Dehkordi,

Negar Raissi-Dehkordi,

Hamed Ebrahimibagha

и другие.

Frontiers in Medicine, Год журнала: 2025, Номер 12

Опубликована: Фев. 26, 2025

Chronic and acute wounds represent significant challenges in healthcare, often leading to prolonged recovery times increased complications. While chronic wounds, such as diabetic foot ulcers venous leg ulcers, persist due underlying conditions biofilm formation, including surgical incisions burns, can also benefit from innovative therapeutic approaches. Cold atmospheric plasma (CAP) has emerged a promising non-invasive therapy capable of enhancing wound healing outcomes across both types. This review examines the cellular molecular mechanisms by which CAP promotes repair, focusing on its modulation inflammation, stimulation angiogenesis, facilitation tissue remodeling, antimicrobial effects, potentially be used regenerative medicine. generates reactive oxygen nitrogen species that influence key processes, accelerating regeneration while reducing bacterial load preventing formation. Clinical applications have demonstrated efficacy improving metrics for wounds. Despite results, translating into routine clinical practice requires addressing standardizing treatment protocols, assessing long-term safety, developing portable devices. Future research should prioritize optimizing parameters exploring combination therapies maximize potential. Overall, represents safe, effective, versatile modality management, with potential significantly improve patient care.

Язык: Английский

Процитировано

0

Targeting Proteostasis Pathways for Cancer Therapy DOI Creative Commons
Xiaofeng Dai,

Renzhe Lyu,

Guanqun Ge

и другие.

Journal of Pharmaceutical Analysis, Год журнала: 2025, Номер unknown, С. 101287 - 101287

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Cold Atmospheric Plasma in Oncology: A Review and Perspectives on Its Application in Veterinary Oncology DOI Creative Commons
André Gustavo Alves Holanda, Luiz Emanuel Campos Francelino, Carlos Eduardo Bezerra de Moura

и другие.

Animals, Год журнала: 2025, Номер 15(7), С. 968 - 968

Опубликована: Март 27, 2025

Cold atmospheric plasma (CAP) is emerging as an innovative approach for cancer treatment because of its selectivity malignant cells and absence significant adverse effects. While modern oncological therapies face challenges such tumor heterogeneity resistance, CAP presents itself a low-cost environmentally sustainable alternative. Its mechanisms action involve reactive oxygen nitrogen species (RONS), UV radiation, electromagnetic fields, which induce cell death. Preclinical clinical studies have demonstrated the efficacy CAP, with devices dielectric barrier discharge (DBD) jet developed to minimize damage healthy cells. Some are already approved use, showing safety efficacy. However, standardization treatments remains challenge due variety parameters used. Although has shown promising cytotoxic effects in vitro animal models, especially different lines, further research, particularly vivo veterinary medicine, needed optimize use maximize combating cancer.

Язык: Английский

Процитировано

0

Effects of Nitro-Oxidative Stress on Biomolecules: Part 1—Non-Reactive Molecular Dynamics Simulations DOI Creative Commons
Maryam Ghasemitarei,

Tayebeh Ghorbi,

Maksudbek Yusupov

и другие.

Biomolecules, Год журнала: 2023, Номер 13(9), С. 1371 - 1371

Опубликована: Сен. 11, 2023

Plasma medicine, or the biomedical application of cold atmospheric plasma (CAP), is an expanding field within research. CAP has demonstrated remarkable versatility in diverse biological applications, including cancer treatment, wound healing, microorganism inactivation, and skin disease therapy. However, precise mechanisms underlying effects remain incompletely understood. The therapeutic are largely attributed to generation reactive oxygen nitrogen species (RONS), which play a crucial role responses induced by CAP. Specifically, RONS produced during treatment have ability chemically modify cell membranes membrane proteins, causing nitro-oxidative stress, thereby leading changes permeability disruption cellular processes. To gain atomic-level insights into these interactions, non-reactive molecular dynamics (MD) simulations emerged as valuable tool. These facilitate examination larger-scale system dynamics, protein-protein protein-membrane interactions. In this comprehensive review, we focus on applications MD studying components interactions at atomic level, providing detailed overview potential medicine. We also review results other studies that not related medicine but explore stress therefore important for broader understanding

Язык: Английский

Процитировано

12

Innovative Therapeutic Approach Targeting Colon Cancer Stem Cells: Transitional Cold Atmospheric Plasma DOI Creative Commons
Abolfazl Soulat, Taghi Mohsenpour, Leila Roshangar

и другие.

ACS Omega, Год журнала: 2025, Номер 10(12), С. 12109 - 12121

Опубликована: Март 6, 2025

Transitional cold atmospheric plasma (TCAP) represents a novel technique for generating remotely from primary source. It consists of partially nonthermal ionized gas mixture containing charged and neutral particles, photons, free radicals. In recent years, TCAP has attracted considerable attention in biomedical applications. order to evaluate colon cancer stem cells' (CCSCs) proliferation, apoptotic induction, inflammatory response, survival, was utilized both directly indirectly this study. Using argon helium gases, continuously delivered two stages during the experiment. For direct state, irradiated onto CCSCs 3 5 min. indirect technique, Matrigel treated with min before introduction cells. vitro assays demonstrated that exposure significantly reduced viability CCSCs; application had greater impacts than argon. Numerous investigations confirmed induction apoptosis, showing groups more cells altered cellular structures controls (****p < 0.0001). A substantial increase Bax/Bcl-2 ratio found by analyzing expression Bax Bcl-2 genes, indicating increased susceptibility apoptosis (*p = 0.0177 ***p 0.0004). The higher efficacy mode further highlighted marker analysis, which showed significant reduction interleukin-6 interleukin-8 TCAP-helium compared TCAP-argon (**p 0.0015 0.0007). Lastly, proliferation test, relies on Ki-67 expression, noteworthy decline all TCAP-treated groups, group exhibiting most robust impact 0.0014). Overall, findings highlight potential TCAP, particularly helium, as promising approach selectively targeting providing insights into its therapeutic mechanisms treatment. therefore, emerges unique strategy applications cell-targeted therapies.

Язык: Английский

Процитировано

0